Express Pharma
DECEMBER 24, 2024
The impact of packaging is felt only when it does not do its job and therefore pharmaceutical companies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. sq mm of material – there is more than 20 per cent reduction of packaging material. per cent CAGR.
STAT
OCTOBER 10, 2024
billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
DECEMBER 4, 2024
The ADAPT X feeder is designed to accommodate complex and unconventional tablet shapes, providing flexibility for diverse packaging requirements. Additionally, the feeder features tool-less changeovers and precise product placement to reduce downtime and improve packaging efficiency. High-speed operation: Offers speeds of up to 13.2
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 billion in 2028, according to a report by Arizton. Having been valued at $27.04
European Pharmaceutical Review
DECEMBER 23, 2022
Astellas Pharma, Eisai, Daiichi Sankyo and Takeda have agreed to collaborate to reduce the environmental burden in the field of pharmaceutical packaging. As part of the collaboration, the four pharma companies plan to share knowledge on packaging technologies to reduce environmental burden. .
STAT
JULY 26, 2023
There are major packages on so-called PBM reform percolating in at least six different congressional committees. Pharmacy benefit managers are companies employed by insurers to negotiate lower drug costs with pharmaceutical companies. Most have bipartisan support, and there seems to be genuine momentum to do something.
STAT
JULY 18, 2023
The Swedish pharmaceutical company, which makes almost all of its money from U.S. That is, everything but its digital therapies pipeline.
Expert insights. Personalized for you.
105 
Let's personalize your content